Demonstrates a new screening tool for identifying neuropathic pain in outpatient settings, highlighting its potential for improved diagnosis.
The ACT tool is a rapid screening tool for identifying neuropathic pain in the busy clinic, with acceptable sensitivity and specificity compared to DN4. The brevity and ease of patient self-administration of ACT make it promising for integration into busy outpatient workflows to improve the diagnosis of painful DPN.
No takes yet. Share an insight, caveat, or question.
Gad et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: